President Donald Trump's pick for health secretary, Robert F. Kennedy Jr., said Thursday he believes anti-obesity drugs "have ...

Amy Burroughs, Terns Pharma CEO, joins 'Closing Bell Overtime' to talk progress in its GLP-1 drug development.

Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...

Musk's plan to cut $2 trillion in federal spending could clash with his proposal to subsidize a drug costing up to $1,000 a ...

Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.

Barriers to accessing GLP-1 medications are beginning to break down as drug manufacturers, insurers, and lawmakers look to expand availability, lower costs, and address continued high demand.

In the age of weight-loss drugs like Ozempic and Wegovy, major food companies are adding new products to their lineups, The ...

The View” co-host Whoopi Goldberg accused Health and Human Services (HHS) nominee Robert F. Kennedy Jr. of fat shaming ...

A few years ago, West Virginia, which has the highest obesity rate in the nation, quietly began a small and unusual pilot ...

The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of ...

Food and beverage was not short of drama or two in 2024, with some of the biggest stories gripping the sector almost from day ...